http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103980198-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate | 2013-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103980198-B |
titleOfInvention | Alkaloid Casuarinine H and the purposes in preparation treatment nerve degenerative diseases medicine thereof |
abstract | nullThe invention belongs to pharmaceutical technology field,Relate to alkaloid Casuarinine H and new medical use thereof in rattan lycopod extract,It is specifically related to alkaloid Casuarinine H purposes in preparation treatment nerve degenerative diseases medicine in rattan lycopod extract,The present invention passes through oxidative stress in-vitro screening model,Alkaloid Casuarinine H in rattan lycopod extract has been carried out activity research,Experiment display,The cellular damage that oxidative stress is caused by alkaloid Casuarinine H has significant protective effect,Described alkaloid Casuarinine H can be used alone or share,Or be combined with suitable excipient,Conventionally make oral or non-oral dosage forms,As made tablet、Capsule、Particle or injection,It is applied to the medicine of preparation treatment nerve degenerative diseases,Include but not limited to Alzheimer disease or Parkinson's disease etc.. |
priorityDate | 2013-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.